Bromide-Val-Cit-PAB-MMAE is a synthetic antibody-drug conjugate (ADC) coupled to a bromide group, which is a very good leaving group for nucleophilic substitution reactions. It contains a protease-sensitive Val-Cit dipeptide and an MMAE payload, which is a synthetic antineoplastic agent that can be attached to a monoclonal antibody (mAb) for targeting cancer cells. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.
Usually ships within 24 hours.